Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | NAAA | Q02083 | 3/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6614810 | 0.90 | POLB (0.49) | TSHRHTTHPGDL3MBTL1ALDH1A1 | |
| SCHEMBL6764380 | 0.84 | POLB (0.45) | TSHRHTTHPGDSMN1; SMN2L3MBTL1 | |
| SCHEMBL6762818 | 0.83 | HPGD (0.49) | TSHRHTTHPGDSMN1; SMN2L3MBTL1 | |
| SCHEMBL4481449 | 0.83 | MAPK1 (0.40) | TSHRHPGDL3MBTL1LMNAMEN1 | |
| SCHEMBL4490802 | 0.73 | — | — | |
| SCHEMBL3092684 | 0.72 | ALDH1A1 (0.81) | TSHRHTTHPGDSMN1; SMN2L3MBTL1 | |
| SCHEMBL4158767 | 0.71 | SMN1; SMN2 (0.62) | TSHRHTTHPGDSMN1; SMN2NAAA | |
| SCHEMBL30865472 | 0.71 | HPGD (0.79) | TSHRHTTHPGDSMN1; SMN2NAAA | |
| SCHEMBL30865488 | 0.71 | HPGD (0.79) | TSHRHTTHPGDSMN1; SMN2NAAA | |
| SCHEMBL30865420 | 0.71 | HPGD (0.79) | TSHRHTTHPGDSMN1; SMN2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120209007-A9 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-08-16 | — | — | US | disclosed |
| US-20110319629-A1 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-12-29 | — | — | US | disclosed |
| EP-2396289-A1 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | Agency For Science, Technology And Research (SG) | 2011-12-21 | — | — | EP | disclosed |
| US-20100249443-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-09-30 | — | — | US | disclosed |
| WO-2010093336-A1 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-08-19 | — | — | WO | disclosed |
| WO-2010093327-A1 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-08-19 | — | — | WO | disclosed |
| US-20100185000-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-07-22 | — | — | US | disclosed |
| US-20100179343-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-07-15 | — | — | US | disclosed |
| US-7732544-B2 | Titanium compound and process for producing optically active cyanohydrins | MITSUI CHEMICALS, INC. (JP) | 2010-06-08 | — | — | US | disclosed |
| EP-2190851-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | Agency for Science, Technology and Research (SG) | 2010-06-02 | — | — | EP | disclosed |
| EP-2137197-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | Agency for Science, Technology And Research (SG) | 2009-12-30 | — | — | EP | disclosed |
| EP-1806336-B1 | TITANIUM COMPOUND AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRINS | MITSUI CHEMICALS INC (JP) | 2009-09-30 | — | — | EP | disclosed |
| WO-2009041919-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-04-02 | — | — | WO | disclosed |
| WO-2008121074-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2008-10-09 | — | — | WO | disclosed |
| WO-2008121076-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2008-10-09 | — | — | WO | disclosed |
| US-20070265463-A1 | Titanium Compound and Process for Producing Optically Active Cyanohydrins | MITSUI CHEMICALS, INC. (JP) | 2007-11-15 | — | — | US | disclosed |
| EP-1806336-A1 | TITANIUM COMPOUND AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRINS | Mitsui Chemicals, Inc. (JP) | 2007-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179343-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | TDO2, AOX1, DAO | TSHR 770/4885HTT 4703/4885HPGD 4279/4885 |
| US-20100185000-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | ABL1, CD59, TDO2 | TSHR 631/4885HTT 3052/4885HPGD 4812/4885 |
| US-20070265463-A1 | Titanium Compound and Process for Producing Optically Active Cyanohydrins | WNT1, C3AR1, TDO2 | TSHR 797/4885HTT 2945/4885HPGD 3904/4885 |
| US-20110319629-A1 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | ABL1, TYR, CD59 | TSHR 245/4885HTT 2188/4885HPGD 4530/4885 |
| US-20100249443-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | ABL1, CD59, TDO2 | TSHR 631/4885HTT 3052/4885HPGD 4812/4885 |
| US-20120209007-A9 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | ABL1, TYR, CD59 | TSHR 245/4885HTT 2188/4885HPGD 4530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.